stockrowOric Pharmaceuticals, Inc. (ORIC) vs Rigel Pharmaceuticals, Inc. (RIGL)
- Oric Pharmaceuticals, Inc. ORIC 8.80 +3.65%
- Rigel Pharmaceuticals, Inc. RIGL 39.59 −13.39%
Oric Pharmaceuticals, Inc. and Rigel Pharmaceuticals, Inc. are both Biotechnology companies. Oric Pharmaceuticals, Inc. and Rigel Pharmaceuticals, Inc. are of similar size ($880.0M and $853.9M). Oric Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Rigel Pharmaceuticals, Inc. trades at 2.4×. Rigel Pharmaceuticals, Inc. has the higher net margin (106.6% vs 0.00%) and the higher return on invested capital (13.7% vs −83.8%). Across the 13 metrics below, Rigel Pharmaceuticals, Inc. leads on 12 and Oric Pharmaceuticals, Inc. on 1.
Valuation
Profitability
| Metric | ORIC | RIGL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 89.64% | 68.51% |
| Operating margin | 0.00% | 26.28% | 0.00% |
| Net margin | 0.00% | 106.59% | 0.00% |
| Free cash flow margin | 0.00% | 31.20% | 0.00% |
| Return on equity | (39.80%) | 109.18% | (51.96%) |
| Return on assets | (37.35%) | 80.16% | (46.06%) |
| Return on invested capital | (83.77%) | 13.69% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack